Dr. U. Muhammed Rafi

Employment

• The New College Assistant professor

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (8)

• Synthesis, crystal structure, and in silico molecular docking studies of 4-hydroxy-3,5-dimethoxybenzaldehyde (6-chloropyridazin-3-yl)hydrazone monohydrate
  Acta Crystallographica Section E Crystallographic Communications 2025 DOI: 10.1107/s205698902500252x
  +Save
• Theoretical, antioxidant, antidiabetic and in silico molecular docking and pharmacokinetics studies of heteroleptic oxovanadium(IV) complexes of thiosemicarbazone-based ligands and diclofenac
  Journal of Biomolecular Structure and Dynamics 2024 DOI: 10.1080/07391102.2023.2246565
  +Save
• Theoretical, single crystal and molecular docking analysis of tetrazolo[1,5-a]pyrimidine-6-carboxylate derivatives
  Journal of Molecular Structure 2022 DOI: 10.1016/j.molstruc.2021.131706
  +Save
• DNA profiling and in vitro cytotoxicity studies of tetrazolo[1,5-a]pyrimidine-based copper(II) complexes
  BioMetals 2019 DOI: 10.1007/s10534-019-00196-2
  +Save
• In vitro anti-proliferative and in silico docking studies of heteroleptic copper(II) complexes of pyridazine-based ligands and ciprofloxacin
  Applied Organometallic Chemistry 2019 DOI: 10.1002/aoc.4946
  +Save
• Pyridazine-based heteroleptic copper(II) complexes as potent anticancer drugs by inducing apoptosis and S-phase arrest in breast cancer cell
  Inorganica Chimica Acta 2018 DOI: 10.1016/j.ica.2018.06.007
  +Save
• Tetrazolo[1,5-a]pyrimidine-based metal(II) complexes as therapeutic agents: DNA interaction, targeting topoisomerase I and cyclin-dependent kinase studies
  Inorganic and Nano-Metal Chemistry 2018 DOI: 10.1080/24701556.2019.1571514
  +Save
• New pyridazine-based binuclear nickel(II), copper(II) and zinc(II) complexes as prospective anticancer agents
  New Journal of Chemistry 2016 DOI: 10.1039/c5nj02739j
  +Save